Standards of Medical Care in Diabetes—2019 Abridged for Primary Care Providers
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Metformin is widely used as a first-line treatment for type 2 diabetes mellitus owing to its excellent tolerability, safety profile, and lack of hypoglycemic effect.
“Isolated from French lilac in 1920s, metformin (dimethylbiguanide) has been widely used as a first-line treatment for type 2 diabetes mellitus (DM2), owing to its excellent tolerability, safety profile, and lack of hypoglycemic effect (3–6).”
From GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin (2020) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
McCormack, J. P., Martin, S. A., & Newman, D. H. (2015) · Diabetes Care · doi:10.2337/dc15-0074 · Cited by 6 · see citing works
[Decision Cycle for Patient-Centered Glycemic Management in Type 2 Diabetes].
Hsu, H.-C., Lee, Y.-J., & Wang, R.-H. (2019) · Hu li za zhi The journal of nursing · doi:10.6224/jn.201912_66(6).02 · Cited by 2
Flagged first, then by citations
9 of the 11 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
KDIGO 2020 Clinical practice guideline for diabetes management in chronic kidney disease
de Boer, I. H., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.06.019 · Cited by 1,399 · see citing works
Metformin: Mechanisms in Human Obesity and Weight Loss
Yerevanian, A., & Soukas, A. A. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00335-3 · Cited by 414 · see citing works
Curcumin and Type 2 Diabetes Mellitus: Prevention and Treatment
Pivari, F., Mingione, A., Brasacchio, C., & Soldati, L. (2019) · Nutrients · doi:10.3390/nu11081837 · Cited by 377 · see citing works
“It is well known that T2DM is a preventable disease [5].”
BackgroundSaher, T., Al-Worafi, Y., Iqbal, M. N., Wahid, A., Iqbal, Q., Khan, A., Atif, M., & Ahmad, N. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.978345 · Cited by 7 · see citing works
“Guidelines recommend that if in a diabetic patient without comorbidity, first-line therapy is insufficient to control blood glucose levels, any one of gliptins, thiazolidinediones, sulfonylureas and SGLT2-I should be added as a second-line agent (7).”
BackgroundMethodInfluentialLi, Z., Cheng, Y., Wang, D., Chen, H., Chen, H., Ming, W.-K., & Wang, Z. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3076463 · Cited by 231 · see citing works
“After delivery, these affected women are advised to perform glucose tolerance test as to screen for type 2 diabetes mellitus (T2DM) [1].”
BackgroundBonner, R., Albajrami, O., Hudspeth, J. C., & Upadhyay, A. (2020) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2020.08.004 · Cited by 189 · see citing works
Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008?
Siegel, K. R., Ali, M. K., Zhou, X., Ng, B. P., Jawanda, S., Proia, K. K., Zhang, X., Gregg, E. W., Albright, A. L., & Zhang, P. (2020) · Diabetes Care · doi:10.2337/dci20-0017 · Cited by 168 · see citing works
Navaneethan, S. D., Zoungas, S., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Liew, A., Michos, E. D., Olowu, W. A., Sadusky, T., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-5938 · Cited by 165 · see citing works
Cousin, E., Duncan, B. B., Stein, C., Ong, K. L., Vos, T., Abbafati, C., Abbasi-Kangevari, M., Abdelmasseh, M., Abdoli, A., Abd-Rabu, R., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00349-1 · Cited by 142 · see citing works
Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care
Watts, G. F., Gidding, S. S., Mata, P., Pang, J., SULLIVAN, D. R., Yamashita, S., Raal, F. J., Santos, R. D., & Ray, K. K. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0325-8 · Cited by 138 · see citing works
Gaike, A. H., Paul, D., Bhute, S. S., Dhotre, D. P., Pande, P., Upadhyaya, S., Reddy, Y. B. S., Sampath, R., Ghosh, D., Chandraprabha, D., et al. (2020) · mSystems · doi:10.1128/msystems.00578-19 · Cited by 130 · see citing works
Kaufman, A., Abuqayyas, L., Denney, W. S., Tillman, E. J., & Rolph, T. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100057 · Cited by 131 · see citing works
Type 2 Diabetes: How Much of an Autoimmune Disease?
de Candia, P., Prattichizzo, F., Garavelli, S., Rosa, V. D., Galgani, M., Rella, F. D., Spagnuolo, M. I., Colamatteo, A., Fusco, C., Micillo, T., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00451 · Cited by 118 · see citing works
Vadiveloo, M., Lichtenstein, A. H., Anderson, C., Aspry, K., Foraker, R., Griggs, S., Hayman, L. L., Johnston, E., Stone, N. J., Thorndike, A. N., et al. (2020) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000094 · Cited by 112 · see citing works
<p>Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician’s Guide</p>
Simes, B. C., & MacGregor, G. G. (2019) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s212003 · Cited by 103 · see citing works
Wu, G., Bai, Z., Wan, Y., Shi, H., Huang, X., & Nie, S. (2019) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2019.105456 · Cited by 101 · see citing works
Pinheiro, T., Marques, A. C., Carvalho, P. A., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c19089 · Cited by 100 · see citing works
Hildebrand, J. A., Billimek, J., Lee, J., Sorkin, D. H., Olshansky, E. F., Clancy, S., & Evangelista, L. S. (2019) · Patient Education and Counseling · doi:10.1016/j.pec.2019.09.009 · Cited by 106 · see citing works
Cardiometabolic Comorbidities in Cancer Survivors
Zullig, L. L., Sung, A. D., Khouri, M. G., Jazowski, S. A., Shah, N. P., Sitlinger, A. P., Blalock, D. V., Whitney, C. A., Kikuchi, R., Bosworth, H. B., et al. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.03.005 · Cited by 102 · see citing works
Mersha, A. G., Tollosa, D. N., Bagade, T., & Eftekhari, P. (2022) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2022.110991 · Cited by 104 · see citing works
Engineering digital biomarkers of interstitial glucose from noninvasive smartwatches
Bent, B., Cho, P. J., Henriquez, M., Wittmann, A., Thacker, C., Feinglos, M. N., Crowley, M. J., & Dunn, J. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00465-w · Cited by 99 · see citing works
Das, T., Takkar, B., Sivaprasad, S., Thanksphon, T., Taylor, H. R., Wiedemann, P., Németh, J., Nayar, P. D., Rani, P. K., & Khandekar, R. B. (2021) · Eye · doi:10.1038/s41433-021-01572-4 · Cited by 85 · see citing works
Moriconi, E., Camajani, E., Fabbri, A., Lenzi, A., & Caprio, M. (2021) · Nutrients · doi:10.3390/nu13030758 · Cited by 85 · see citing works
Jamthikar, A. D., Gupta, D., Saba, L., Khanna, N. N., Araki, T., Višković, K., Mavrogeni, S. I., Laird, J. R., Pareek, G., Miner, M. M., et al. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2020.01.07 · Cited by 82 · see citing works
Human beige adipocytes for drug discovery and cell therapy in metabolic diseases
Singh, A. M., Zhang, L., Avery, J. W., Yin, A., Du, Y., Wang, H., Li, Z., Fu, H., Yin, H., & Dalton, S. (2020) · Nature Communications · doi:10.1038/s41467-020-16340-3 · Cited by 78 · see citing works
Kanbour, S., Jones, M., Abusamaan, M. S., NASS, C. M., Everett, E. M., Wolf, R. M., Sidhaye, A. R., & Mathioudakis, N. N. (2022) · Diabetes Care · doi:10.2337/dc22-1055 · Cited by 84 · see citing works
Vijayakumar, S., Divya, M., Vaseeharan, B., Chen, J., Biruntha, M., Silva, L. P., Durán‐Lara, E. F., Shreema, K., Ranjan, S., & Dasgupta, N. (2020) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-020-01713-4 · Cited by 75 · see citing works
Kandwal, A., Igbe, T., Li, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60806-9 · Cited by 74 · see citing works
Giglio, R. V., Sasso, B. L., Agnello, L., Bivona, G., Maniscalco, R., Ligi, D., Mannello, F., & Ciaccio, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113634 · Cited by 72 · see citing works
Application of Telemedicine in Diabetes Care: The Time is Now
Aberer, F., Hochfellner, D. A., & Mader, J. K. (2021) · Diabetes Therapy · doi:10.1007/s13300-020-00996-7 · Cited by 74 · see citing works
Silva-Tinoco, R., Cuatecontzi-Xochitiotzi, T., de la Torre-Saldaña, V., León-García, E., Serna-Alvarado, J., Orea‐Tejeda, A., Castillo‐Martínez, L., Gay, J. G., de León, D. F. C., & Prada, D. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00604-6 · Cited by 65 · see citing works
A Comprehensive Review on Weight Loss Associated with Anti-Diabetic Medications
Haddad, F., Dokmak, G., Bader, M., & Karaman, R. (2023) · Life · doi:10.3390/life13041012 · Cited by 67 · see citing works
“Because of its exceptional effectiveness, safety profile, tolerance, and lack of hypoglycemia, metformin (Figure 1a), an antihyperglycemic biguanide, is well-known as a cornerstone and first-line treatment of T2DM that decrease hepatic glucose production (Figure 2) [19,20].”
BackgroundMechanisms and Evidence for Heart Failure Benefits from SGLT2 Inhibitors
Wójcik, C., & Warden, B. A. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1219-4 · Cited by 61 · see citing works
Overview of Therapeutic Inertia in Diabetes: Prevalence, Causes, and Consequences
Karam, S., Dendy, J. A., Polu, S., & Blonde, L. (2020) · Diabetes Spectrum · doi:10.2337/ds19-0029 · Cited by 66 · see citing works
Bariatric surgery and health outcomes: An umbrella analysis
Liao, J., Yin, Y., Zhong, J., Chen, Y., Chen, Y., Wen, Y., & Cai, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1016613 · Cited by 59 · see citing works
A Systematic Review on Synthetic Drugs and Phytopharmaceuticals Used to Manage Diabetes
Banerjee, M., Khursheed, R., Yadav, A., Singh, S. K., Gulati, M., Pandey, D. K., Prabhakar, P. K., Kumar, R., Porwal, O., Awasthi, A., et al. (2019) · Current Diabetes Reviews · doi:10.2174/1573399815666190822165141 · Cited by 57 · see citing works
Diabetes mellitus type 2 in adults
Dedov, I. I., Shestakova, M. V., Mayorov, A. Y., Шамхалова, М. Ш., Sukhareva, O. Y., Galstyan, G. R., Tokmakova, A. Y., Nikonova, T. V., Surkova, E. V., Кононенко, И. В., et al. (2020) · Diabetes Mellitus · doi:10.14341/dm12507 · Cited by 58 · see citing works
The risk of tooth loss in patients with diabetes: A systematic review and meta‐analysis
Weijdijk, L. P. M., Žiūkaitė, L., van der Weijden, G. A., Bakker, E. W. P., & Slot, D. E. (2021) · International Journal of Dental Hygiene · doi:10.1111/idh.12512 · Cited by 51 · see citing works
Improvement in Glycemic and Lipid Profiles in Type 2 Diabetics with a 90-Day Ketogenic Diet
Walton, C. M., Perry, K., Hart, R. H., Berry, S. L., & Bikman, B. T. (2019) · Journal of Diabetes Research · doi:10.1155/2019/8681959 · Cited by 50 · see citing works
“Nevertheless, the use of carbohydrate restriction in the treatment of diabetes is now sufficiently well established and accepted that the American Diabetes Association, in their recently published Standards of Medical Care in Diabetes, stated, “research indicates that low-carbohydrate eating plans may result in improv…”
BackgroundIshiba, H., Sumida, Y., Seko, Y., Tanaka, S., Yoneda, M., Hyogo, H., Ono, M., Fujii, H., Eguchi, Y., Suzuki, Y., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1637 · Cited by 51 · see citing works
Dyslipidemia: A Trigger for Coronary Heart Disease in Romanian Patients with Diabetes
Găman, M., Cozma, M.-A., Dobrică, E.-C., Bacalbașa, N., Bratu, O. G., & Diaconu, C. C. (2020) · Metabolites · doi:10.3390/metabo10050195 · Cited by 49 · see citing works
Serum liver enzymes and diabetes from the Rafsanjan cohort study
Karimabad, M. N., Khalili, P., Ayoobi, F., Nadimi, A. E., Vecchia, C. L., & Jamali, Z. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01042-2 · Cited by 51 · see citing works
Beneficial Effects of Spirulina Supplementation in the Management of Cardiovascular Diseases
Prete, V., Abate, A. C., Pietro, P. D., Lucia, M. D., Vecchione, C., & Carrizzo, A. (2024) · Nutrients · doi:10.3390/nu16050642 · Cited by 49 · see citing works
Self-monitoring diabetes with multiple mobile health devices
Shaw, R. J., Yang, Q., Barnes, A. H., Hatch, D., Crowley, M. J. P., Vorderstrasse, A. A., Vaughn, J., Diane, A., Lewinski, A. A., Jiang, M., et al. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa007 · Cited by 46 · see citing works
Management of an emergency tooth extraction in diabetic patients on the dental chair
Gazal, G. (2019) · The Saudi Dental Journal · doi:10.1016/j.sdentj.2019.07.004 · Cited by 46 · see citing works
Shiferaw, W. S., Akalu, T. Y., Desta, M., Kassie, A. M., Petrucka, P. M., & Aynalem, Y. A. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-049806 · Cited by 46 · see citing works
Bartnik, K., Koba, M., & Smietana, M. J. (2023) · Measurement · doi:10.1016/j.measurement.2023.113818 · Cited by 46 · see citing works
Dapagliflozin: A Review in Type 1 Diabetes
Paik, J., & Blair, H. A. (2019) · Drugs · doi:10.1007/s40265-019-01213-x · Cited by 46 · see citing works
Zheng, T., Bian, F., Chen, L., Wang, Q., & Jin, S. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00402-4 · Cited by 47 · see citing works
Negera, G. Z., & Epiphanio, D. C. (2020) · International Journal of Endocrinology · doi:10.1155/2020/1512376 · Cited by 45 · see citing works
Damanhouri, Z. A., Alkreathy, H. M., Alharbi, F. A., Abualhamail, H., & Ahmad, M. S. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.77206 · Cited by 48 · see citing works
Combined training increases thermogenic fat activity in patients with overweight and type 2 diabetes
Bonfante, I. L. P., Monfort‐Pires, M., Duft, R. G., Mateus, K. C. D. S., Júnior, J. C. D. L., Trombeta, J. C. D. S., Finardi, E. A. R., Brunelli, D. T., Morari, J., de Lima, J. A. B., et al. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01086-3 · Cited by 41 · see citing works
Zheng, Y., Gou, X., Zhang, L., Gao, H., Wei, Y., Yu, X., Pang, B., Tian, J., Tong, X., & Li, M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00360 · Cited by 43 · see citing works
Dzaye, O. D. A., Dudum, R., Reiter–Brennan, C., Kianoush, S., Tota-Maharaj, R., Cainzos‐Achirica, M., & Blaha, M. J. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.10.007 · Cited by 40 · see citing works
Silva-Tinoco, R., Cuatecontzi-Xochitiotzi, T., de la Torre-Saldaña, V., León-García, E., Serna-Alvarado, J., GUZMAN-OLVERA, E. B., Cabrera, D., Gay, J. G., & Prada, D. (2020) · International Journal for Equity in Health · doi:10.1186/s12939-020-01188-2 · Cited by 40 · see citing works
Metformin: new applications for an old drug
Naseri, A., Sanaie, S., Hamzehzadeh, S., Sahebari, S. S., Hosseini, M., Gholipour-khalili, E., Rezazadeh-Gavgani, E., Majidazar, R., Seraji, P., Daneshvar, S., et al. (2022) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2022-0252 · Cited by 39 · see citing works
GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin
Ouyang, J., Isnard, S., Lin, J., Fombuena, B., Peng, X., Chen, Y., & Routy, J.-P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.581839 · Cited by 39 · see citing works
Kuroda, H., Fujiwara, Y., Abe, T., Nagasawa, T., Oguri, T., Noguchi, S., Kamiyama, N., & Takikawa, Y. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249493 · Cited by 38 · see citing works
“Type II diabetes mellitus was diagnosed based on the American Diabetes Association criteria [28].”
MethodCai, S., Zhu, J., Sun, L., Fan, C., Zhong, Y., Shen, Q., & Li, Y. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00576 · Cited by 34 · see citing works
Illness Perceptions, HbA1c, And Adherence In Type 2 Diabetes In Saudi Arabia
Alyami, M. M., Serlachius, A. S., Mokhtar, I., & Broadbent, E. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s228670 · Cited by 38 · see citing works
Explainable Machine Learning‐Based Prediction Model for Diabetic Nephropathy
Yin, J.-M., Li, Y., Xue, J.-T., Zong, G.-W., Fang, Z.-Z., & Zou, L. (2024) · Journal of Diabetes Research · doi:10.1155/2024/8857453 · Cited by 36 · see citing works
Vail, D. G., Callaway, N. F., Ludwig, C. A., Saroj, N., & Moshfeghi, D. M. (2019) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2019.05.029 · Cited by 36 · see citing works
Levels of ankle–brachial index and the risk of diabetes mellitus complications
Alves‐Cabratosa, L., Comas‐Cufí, M., Ponjoan, A., García-Gil, M., Martí‐Lluch, R., Blanch, J., Elosua-Bayés, M., Parramon, D., Camós, L., Guzmán, L., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000977 · Cited by 36 · see citing works
The role of mitochondria in metabolic disease: a special emphasis on heart dysfunction
Federico, M., de la Fuente, S., Palomeque, J., & Sheu, S. (2021) · The Journal of Physiology · doi:10.1113/jp279376 · Cited by 37 · see citing works
Wani, K., Alfawaz, H., Alnaami, A. M., Sabico, S., Khattak, M. N. K., Al-Attas, O. S., Alokail, M. S., Alharbi, M., Chrousos, G. P., Kumar, S., et al. (2020) · Nutrients · doi:10.3390/nu12020464 · Cited by 36 · see citing works
Sakak, F. R., Moslehi, N., Niroomand, M., & Mirmiran, P. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02419-6 · Cited by 35 · see citing works
Espinoza, P., Varela, C. A., Vargas, I., Ortega, G., Silva, P. A., Boehmer, K. B., & Montori, V. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241485 · Cited by 34 · see citing works
“The rigidity of the protocols fails to account for the importance of considering patient characteristics–such as patient’s perceptions and beliefs [17] when creating a health care plan [20] that makes practical sense in the Table 2.”
BackgroundTian, Y., Jing, G., Ma, M., Yin, R., & Zhang, M. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105848 · Cited by 38 · see citing works
“…overall health; physical therapists can help patients improve mobility and reduce or prevent other complications caused by T2D; clinical psychologists can provide psychological support for patients, helping them cope with emotional and behavioral issues related to T2D (American Diabetes, 2019).”
BackgroundBailey, T. S., Wu, J., Zhou, F. L., Gupta, R. A., Menon, A. A., Berhanu, P., Westerbacka, J., Vleet, J. V., & Blonde, L. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13818 · Cited by 33 · see citing works
Horii, T., Iwasawa, M., Kabeya, Y., & Atuda, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-49424-2 · Cited by 33 · see citing works
Luo, H., Li, J., Feng, X., Sun, X., Li, J., Yang, X., & Fang, Z. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000877 · Cited by 33 · see citing works
Tong, J., Wu, L., Chen, Y., Guan, X., Tian, F., Zhang, H.-F., Liu, K., Yin, A., Wu, X., & Prof, J.-M. N. (2021) · Endocrine · doi:10.1007/s12020-021-02831-w · Cited by 34 · see citing works
Nutritional Strategies in Prediabetes: A Scoping Review of Recent Evidence
Yau, J. W., Thor, S. M., & Ramadas, A. (2020) · Nutrients · doi:10.3390/nu12102990 · Cited by 32 · see citing works
Gyrard, A., Tabeau, K., Fiorini, L., Kung, A., Sengès, É., de Mul, M., Giuliani, F., Lefebvre, D., Hoshino, H., Fabbricotti, I. N., et al. (2021) · International Journal of Social Robotics · doi:10.1007/s12369-021-00821-6 · Cited by 32 · see citing works
Le, T. D., Nguyen, N. P. T., Tran, T. T. H., Cong, T. L., Nguyen, L. H. T., Nhu, B. D., Nguyen, S. T., Ngo, M. V., Dinh, T. H., Nguyen, H. T., et al. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s344532 · Cited by 36 · see citing works
Ogunwole, S. M., Chen, X., Mitta, S., Minhas, A., Sharma, G. V., Zakaria, S., Vaught, A. “. J., Toth‐Manikowski, S. M., & Smith, G. N. (2021) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2021.08.004 · Cited by 33 · see citing works
Hadziabdic, E., Pettersson, S., Marklund-Bau, H., & Hjelm, K. (2020) · Primary Health Care Research & Development · doi:10.1017/s1463423620000493 · Cited by 30 · see citing works
Karizi, S. R., Armanmehr, F., Azadi, H. G., Zahroodi, H. S., Ghalibaf, A. M., Bazzaz, B. S. F., Abbaspour, M., Boskabadi, S. J., Eslami, S., & Taherzadeh, Z. (2023) · Phytotherapy Research · doi:10.1002/ptr.7674 · Cited by 32 · see citing works
Reifsnider, O. S., Kansal, A., Pimple, P. M., Ribero, V. A., Brand, S. B., & Shetty, S. S. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14268 · Cited by 29 · see citing works
Ansbro, É., Homan, T., Prieto‐Merino, D., Jobanputra, K., Qasem, J., Shoaib, M., Fardous, T., & Perel, P. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003279 · Cited by 30 · see citing works
“5%–8%), it may be reasonable to introduce tighter, individualised treatment targets for many patients in this context, as suggested in similar humanitarian settings [23,39].”
BackgroundGonzález‐Domínguez, Á., Visiedo, F., Domínguez‐Riscart, J., Ruiz-Mateos, B., Sáez-Benito, A., Lechuga-Sancho, A. M., & Mateos, R. M. (2021) · Antioxidants · doi:10.3390/antiox10020244 · Cited by 29 · see citing works
Regassa, L. D., & Tola, A. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00744-3 · Cited by 31 · see citing works
Lee, M.-K., Lee, D. Y., Ahn, H.-Y., & Park, C.-Y. (2021) · JMIR mHealth and uHealth · doi:10.2196/17573 · Cited by 27 · see citing works
Khadra, K. M. A., Bataineh, M. I., Khalil, A. M., & Saleh, J. (2024) · European journal of medical research · doi:10.1186/s40001-024-01906-4 · Cited by 28 · see citing works
Darawshi, S., Yaseen, H., Gorelik, Y., Faor, C., Szalat, A., Abassi, Z. A., Heyman, S. N., & Khamaisi, M. (2020) · Renal Failure · doi:10.1080/0886022x.2020.1801466 · Cited by 27 · see citing works
The Finnish Diabetes Risk Score (FINDRISC), incident diabetes and low-grade inflammation
Pesaro, A. E. P., Bittencourt, M. S., Franken, M., Carvalho, J. A. M., Bernardes, D., Tuomilehto, J. O., & Santos, R. D. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108558 · Cited by 28 · see citing works
Zhao, X., Liu, Y., Zhang, W., et al. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.2.20 · Cited by 27 · see citing works
Salvador, J., Vilarrasa, N., Poyato, F., & Rubio, M. Á. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092834 · Cited by 26 · see citing works
Chen, Y., Rolka, D. B., Xie, H. W., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6945a1 · Cited by 26 · see citing works
Chowdhury, M. H., Chowdhury, M. E. H., & Alqahtani, A. (2024) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2024.105975 · Cited by 27 · see citing works
Gebrie, D., Manyazewal, T., Ejigu, D. A., & Makonnen, E. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s312997 · Cited by 25 · see citing works
Pathak, S., Kearin, K., Kahkoska, A. R., Fuller, K. A., Staats, B. R., Albright, J., Stürmer, T., Buse, J. B., & Urick, B. Y. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0418 · Cited by 25 · see citing works
Wang, Y., Zhao, L., Zhang, J., Wu, Y., Zhang, R., Li, H., Guo, R., Han, Q., Wang, T., Li, L., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00855 · Cited by 24 · see citing works
Macek, P., Terek-Derszniak, M., Biskup, M., Król, H., Smok-Kalwat, J., Góźdź, S. S., & Žák, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092904 · Cited by 25 · see citing works
Federico, M., Zavala, M., Vico, T. A., López, S., Portiansky, E. L., Álvarez, S., Abrille, M. C. V., & Palomeque, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-99118-x · Cited by 22 · see citing works
The elephant in the room: Why cardiologists should stop ignoring type 2 diabetes
O’Keefe, J. H., Nassif, M. E., MAGWIRE, M. L., O’Keefe, E. L., & Lavie, C. J. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.08.001 · Cited by 22 · see citing works
Aoyagi, Y., Yoshida, T., Uchino, S., et al. (2020) · Journal of Intensive Care · doi:10.1186/s40560-020-00489-6 · Cited by 22 · see citing works
Acute Effects of High-Intensity Interval Training on Diabetes Mellitus: A Systematic Review
Teles, G. D. O., da Silva, C. S., Rezende, V. R., & Rebelo, A. C. S. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19127049 · Cited by 22 · see citing works
Anjum, M., Saher, R., & Saeed, M. N. (2024) · PeerJ Computer Science · doi:10.7717/peerj-cs.1971 · Cited by 26 · see citing works
“There are different tests to screen whether a person is diabetic or pre-diabetic in Table 1, and the criteria ( American Diabetes Association, 2019 ) for the screening and diagnosis of pre-diabetes and diabetes are mentioned.”
PNPLA3 I148M Polymorphism in Patients with Nonalcoholic Fatty Liver Disease, Obesity and Prediabetes
Karamfilova, V., Gateva, A., Assyov, Y. S., et al. (2019) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-506 · Cited by 22 · see citing works
- Authors
- American Diabetes Association
- Corresponding author
- American Diabetes Association
- Venue
- Clinical Diabetes
- Publisher
- American Diabetes Association
- Published
- 2019-01-01
- Volume
- 37
- Issue
- 1
- Pages
- 11-34
- ISSN
- 0891-8929 (ISSN-L)
- 1945-4953
- PMC
- PMC6336119
- OpenAlex
- W4239349741
- Cited by
- 539
- References
- 11
- Citations by year
- 2026: 17 · 2025: 43 · 2024: 67 · 2023: 77 · 2022: 83 · 2021: 84 · 2020: 117 · 2019: 47 · 2016: 1 · 2015: 1 · 2013: 1
- FWCI
- 49.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Diabetes (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes mellitus, health care standards, primary care, glycemic control, diabetes management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
